REVIEW
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
Rosa Camila LucchettaI,
, Bruno Salgado RiverosI, Roberto PontaroloI, Rosana Bento RadominskiII, Michel Fleith OtukiIII, Fernando Fernandez-LlimosIV, Cassyano Januário CorrerI
Corresponding author
I Laboratório de Serviços Clínicos e Evidências em Saúde, Departamento de Farmácia, Universidade Federal do Paraná (UFPR), Curitiba, PR, BR
II Serviço de Endocrinologia e Metabolismo, Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, PR, BR
III Departamento de Ciências Farmacêuticas, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, BR
IV Research Institute for Medicines (iMed.ULisboa), Department of Social Pharmacy, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
Read
5228
Timeswas read the article
1300
Total PDF
3928
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 214 | 78 | 292 |
| 2025 11 | 600 | 364 | 964 |
| 2025 10 | 316 | 170 | 486 |
| 2025 9 | 346 | 141 | 487 |
| 2025 8 | 307 | 41 | 348 |
| 2025 7 | 337 | 31 | 368 |
| 2025 6 | 226 | 7 | 233 |
| 2025 5 | 270 | 13 | 283 |
| 2025 4 | 216 | 11 | 227 |
| 2025 3 | 139 | 15 | 154 |
| 2025 2 | 122 | 7 | 129 |
| 2025 1 | 103 | 4 | 107 |
| 2024 12 | 61 | 7 | 68 |
| 2024 11 | 89 | 26 | 115 |
| 2024 10 | 65 | 37 | 102 |
| 2024 9 | 72 | 19 | 91 |
| 2024 8 | 76 | 36 | 112 |
| 2024 7 | 52 | 25 | 77 |
| 2024 6 | 40 | 17 | 57 |
| 2024 5 | 51 | 24 | 75 |
| 2024 4 | 55 | 15 | 70 |
| 2024 3 | 46 | 12 | 58 |
| 2024 2 | 17 | 32 | 49 |
| 2024 1 | 13 | 20 | 33 |
| 2023 12 | 7 | 24 | 31 |
| 2023 11 | 15 | 29 | 44 |
| 2023 10 | 14 | 27 | 41 |
| 2023 9 | 14 | 27 | 41 |
| 2023 8 | 7 | 7 | 14 |
| 2023 7 | 11 | 21 | 32 |
| 2023 6 | 1 | 0 | 1 |
| 2023 5 | 1 | 4 | 5 |
| 2023 4 | 2 | 1 | 3 |
| 2023 3 | 2 | 0 | 2 |
| 2023 1 | 0 | 5 | 5 |
| 2022 12 | 19 | 3 | 22 |
| 2022 11 | 2 | 0 | 2 |
Show all